Liquid Biopsy Clinical Trials
2 recruiting trials for Liquid Biopsy. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Liquid Biopsy clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University Hospital, Montpellier (1), Regina Elena Cancer Institute (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Blood sample/lliquid biopsy (biological, 1 trial), followed by Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx.
Track Liquid Biopsy trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)
Improving personalized cancer treatments and finding the best strategies to treat each patient relies on using new diagnostic technologies. Currently, for colorectal cancer, the...
Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus
Based on the evidence summarized in the introduction, the clinician hypothesize that the detection of the presence and expression of HPV-DNA, certain miRNAs, and a certain...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Liquid Biopsy, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Liquid Biopsy, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Liquid Biopsy, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.